Related Experiment Video

Updated: May 30, 2026

Assessing Respiratory Immune Responses to Haemophilus Influenzae
06:32

Assessing Respiratory Immune Responses to Haemophilus Influenzae

Published on: June 29, 2021

[Determination of capillary plasma C-reactive protein during therapy for acute infectious lung diseases]

V V Makarenko, N F Vavilikhina, T N Kastrikina

    Klinicheskaia Laboratornaia Diagnostika
    |August 20, 2011
    PubMed

    Insights

    Capillary blood C-reactive protein (CRP) effectively monitors infant infectious lung disease treatment. A significant CRP decrease indicates effective antibiotic therapy, showing high sensitivity and specificity for monitoring treatment progress.

    Area of Science:

    • Pediatric Infectious Diseases
    • Clinical Chemistry
    • Biomarker Analysis

    Context:

    • Acute infectious lung diseases are common in infants.
    • Monitoring treatment effectiveness is crucial for pediatric patients.
    • C-reactive protein (CRP) is a known inflammatory marker.

    Purpose:

    • To evaluate the utility of C-reactive protein (CRP) measurement in capillary blood for monitoring antibiotic therapy in infants with acute infectious lung diseases.
    • To compare CRP levels with other inflammatory markers such as leukocytes and erythrocyte sedimentation rate.
    • To determine the sensitivity and specificity of CRP in assessing treatment response.

    Summary:

    • This study analyzed CRP, leukocyte, erythrocyte sedimentation rate, and differential blood count in 66 infants with acute infectious lung diseases.
    • A high correlation was observed between capillary plasma and venous serum CRP concentrations.
    • A significant decrease in CRP levels was noted on the first day of effective antibiotic therapy, with 96% sensitivity and 94% specificity.

    Impact:

    • Capillary blood CRP measurement is a highly sensitive and specific, accessible tool for monitoring infectious lung disease treatment in infants.
    • This method allows for rapid assessment of therapeutic efficacy, potentially improving patient outcomes.
    • The findings support the routine use of capillary CRP monitoring in pediatric infectious disease management.

    Related Concept Videos

    Pneumonia III: Complications and Assessment01:30

    Pneumonia III: Complications and Assessment

    Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
    Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

    Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

    Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
    These markers indicate stress or strain on the heart muscle:
    Natriuretic Peptides (BNP)
    Cardiac myocytes produce these hormones in response to ventricular stretching...